SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Biederstädt, Alexander, Hassan, Zonera, Schneeweis, Christian, Schick, Markus, Schneider, Lara, Muckenhuber, Alexander, Hong, Yingfen, Siegers, Gerrit, Nilsson, Lisa, Wirth, Matthias, Dantes, Zahra, Steiger, Katja, Schunck, Kathrin, Langston, Steve, Lenhof, H-P, Coluccio, Andrea, Orben, Felix, Slawska, Jolanta, Scherger, Anna, Saur, Dieter, Müller, Stefan, Rad, Roland, Weichert, Wilko, Nilsson, Jonas, Reichert, Maximilian, Schneider, Günter, Keller, Ulrich
Published in Gut (01.08.2020)
Published in Gut (01.08.2020)
Get full text
Journal Article
233P Breast cancer organoids mimic disease heterogeneity, allow high-throughput drug screening and show correlation with clinical response
Dantes, Z., Manjunath, A., Ferreira, L., Slawska, J., Steiger, K., Pfarr, N., Bernlochner, K., Hefel, B., Huang, L., Jesinghaus, M., Rosell, R., Kiechle, M., Dantes, M., Lindner, K., Peschel, C., Weichert, W., Paepke, S.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
MA04.09 The MET Inhibitor Tepotinib Potentially Inhibits KRAS G12C and SHOC2 in KRAS G12C Non-Small Cell Lung Cancer (NSCLC)
Rosell, R., Jain, A., Codony-Servat, J., Shivamallu, C., Prasad Kollur, S., Prasad, A., Jantus-Lewintre, E., Ito, M., Cardona, A.F., Arrieta, O., Cao, P., Cai, X., Xing, B., Pedraz-Valdunciel, C., Dantes, Z., Sullivan, I., Aguilar, A., Molina-Vila, M.A., González-Cao, M.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
199P Suppression of mutant Kirsten-RAS (KRAS G12C) non-small cell lung cancer (NSCLC) resistance to KRAS G12C inhibitors by dual inhibition of hepatocyte growth factor receptor (MET) and V-ATPase
Rosell, R., Gómez-Vázquez, J.L., Lewintre, E. Jantus, Ito, M., Cao, P., Cai, X., Xing, B., Fariñas, S. Calabuig, Cardona, A.F., Rodríguez, J.K., Jordán, M. Marco, Valdunciel, C. Pedraz, Molina-Vila, M.A., Codony-Servat, J., Dantes, Z., Aguilar, A., Sullivan, I.G., Horno, I. Moya, Cirera, L., Gonzalez-Cao, M.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
Arming T cells with C-X-C-motive receptor 6 enhances infiltration of pancreatic cancer patient-derived organoids
Ogonek, J., Lutz, J., Dantes, Z., Lesch, S., Stoiber, S., Schuebel, M., Voelkl, L., Ormanns, S., Reichert, M., Endres, S., Kobold, S.
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
32P Observational study to compare in vitro sensitivity to therapy in patients-derived organoids (PDOs) with real life outcome: The ChemoSenPDO study
Garcias-Donas, J., Dantes, Z., Jiménez, B., Yagüe, M., Manjunath, A., Ferreira, L., Hefel, B., Slawska, J., Rodríguez-Moreno, J.F., Sevillano, E., Barquin, A., Dorta Suarez, M., Rodriguez Pascual, J., Millan, C., Lopez, I., Jimenez, L., Müller, A., Barba, M., Ruiz-Llorente, S., Navarro, P.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer
Lesch, S., Blumenberg, V., Stoiber, S., Ogonek, J., Cadilha, B., Dantes, Z., Rataj, F., Dorman, K., Lutz, J., Karches, C., Heise, C., Grassmann, S., Megens, R., Ruehland, S., Di Pilato, M., Pruessmann, J., Ormanns, S., Reischer, A., Duewell, P., Schnurr, M., Subklewe, M., Reichert, M., Mempel, T., Endres, S., Kobold, S.
Published in European journal of cancer (1990) (01.03.2019)
Published in European journal of cancer (1990) (01.03.2019)
Get full text
Journal Article
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs?
Renz, B.W., Graf, S., Dantes, Z., Macchini, M., Vecchiarelli, S., Ricci, C., Wang, T.C., Casadei, R., Di Marco, M., Reichert, M., Kleespies, A., Werner, J.
Published in HPB (Oxford, England) (2019)
Published in HPB (Oxford, England) (2019)
Get full text
Journal Article
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs?
Renz, B.W., Graf, S., Dantes, Z., Macchini, M., Vecchiarelli, S., Ricci, C., Wang, T.C., Casadei, R., Di Marco, M., Reichert, M., Kleespies, A., Werner, J.
Published in HPB (Oxford, England) (2019)
Published in HPB (Oxford, England) (2019)
Get full text
Journal Article
Phosphoproteomics identifies PI3K inhibitor-selective adaptive responses in pancreatic cancer cell therapy and resistance
Cintas, C, Douche, T, Dantes, Z, Mouton-Barbosa, E, Bousquet, Mp, Therville, N, Pont, F, Cayron, C, Ramos-Delgado, F, Thibault, B, Garmy-Susini, B, Cappello, P, Burlet-Schiltz, O, Hirsch, E, Gomez-Brouchet, A, Reichert, M, Guillermet-Guibert, J
Published in bioRxiv (24.11.2020)
Published in bioRxiv (24.11.2020)
Get full text
Paper